Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Amazon ramps up trademarks for pharmacy business

Amazon is signaling it may soon sell prescription drugs in the U.K., Canada and Australia after the company moved to trademark “Amazon Pharmacy” in those countries at the start of 2020, CNBC reported.

Thumbnail

37% of ACOs are taking on downside risk

More accountable care organizations are taking on downside financial risk in the Medicare Shared Savings Program than ever before, with 37% in the program today participating in these arrangements.

Thumbnail

Supreme Court won’t hear ACA lawsuit

The Supreme Court won’t take up the ongoing appeal over the constitutionality of the Affordable Care Act, leaving the decision in the hands of a lower court.

Thumbnail

Another drug company explores $2M-$3M price tag for therapy

The world could soon have a new most expensive drug if an experimental gene therapy for hemophilia patients could come in with a price tag between $2 million and $3 million is approved.

Thumbnail

Will US, Europe work together on AI regulation?

Sundar Pichai, who serves as the CEO for both Alphabet and Google, wants the United States and European Union to work together on developing AI regulations.

 

Thumbnail

Savings impact of alternative payment models proves difficult to project

The Centers for Medicare & Medicaid Innovation savings projections keep moving, underscoring just how difficult it is to estimate the impact of untested alternative payment models, according to a recent analysis from Avalere Health.

Thumbnail

Largest physician specialty group endorses Medicare for all

The American College of Physicians, which represents 159,000 internists in the U.S., has endorsed a single-payer American healthcare system.

Thumbnail

Trump worries about healthcare poll, regrets enacting vaping restrictions

HHS Secretary Alex Azar took some heat from President Trump after a recent poll showed Democrats leading when it came to the issue of healthcare.

 

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.